Zhende Medical Co., Ltd. (SHA:603301)
China
· Delayed Price · Currency is CNY 90.01
+0.13 (0.14%)
Apr 29, 2026, 3:00 PM CST
Zhende Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 23,740 | 18,732 | 5,856 | 6,477 | 10,059 | 11,564 | Upgrade
|
| Market Cap Growth | 312.88% | 219.86% | -9.58% | -35.61% | -13.02% | -14.29% | Upgrade
|
| Enterprise Value | 24,232 | 19,341 | 5,978 | 5,723 | 9,327 | 10,827 | Upgrade
|
| Last Close Price | 90.01 | 70.50 | 21.30 | 23.18 | 34.16 | 45.37 | Upgrade
|
| PE Ratio | 90.03 | 71.82 | 15.21 | 32.64 | 14.80 | 19.41 | Upgrade
|
| Forward PE | 48.39 | 42.34 | 12.67 | 9.13 | 11.70 | 19.82 | Upgrade
|
| PS Ratio | 5.47 | 4.33 | 1.37 | 1.57 | 1.64 | 2.27 | Upgrade
|
| PB Ratio | 3.96 | 3.14 | 0.99 | 1.16 | 1.75 | 2.61 | Upgrade
|
| P/TBV Ratio | 5.96 | 4.77 | 1.41 | 1.63 | 2.23 | 3.59 | Upgrade
|
| P/FCF Ratio | 168.75 | - | - | - | 20.45 | 94.66 | Upgrade
|
| P/OCF Ratio | 41.50 | 34.79 | 12.70 | 14.33 | 8.07 | 14.14 | Upgrade
|
| EV/Sales Ratio | 5.59 | 4.47 | 1.40 | 1.39 | 1.52 | 2.13 | Upgrade
|
| EV/EBITDA Ratio | 33.70 | 28.21 | 9.76 | 12.02 | 9.34 | 12.61 | Upgrade
|
| EV/EBIT Ratio | 62.15 | 49.81 | 15.94 | 24.53 | 11.47 | 14.89 | Upgrade
|
| EV/FCF Ratio | 172.25 | - | - | - | 18.96 | 88.62 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.21 | 0.10 | 0.11 | 0.11 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 1.79 | 1.80 | 0.95 | 1.34 | 0.60 | 0.98 | Upgrade
|
| Debt / FCF Ratio | 9.15 | - | - | - | 1.23 | 6.94 | Upgrade
|
| Net Debt / Equity Ratio | 0.04 | 0.03 | -0.04 | -0.10 | -0.27 | -0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.31 | 0.23 | -0.39 | -1.20 | -1.57 | -0.60 | Upgrade
|
| Net Debt / FCF Ratio | 1.56 | -13.29 | 0.78 | 3.88 | -3.19 | -4.22 | Upgrade
|
| Asset Turnover | 0.53 | 0.54 | 0.57 | 0.54 | 0.86 | 0.79 | Upgrade
|
| Inventory Turnover | 3.47 | 3.75 | 3.63 | 3.30 | 4.61 | 3.51 | Upgrade
|
| Quick Ratio | 1.03 | 1.04 | 1.50 | 1.54 | 1.98 | 1.31 | Upgrade
|
| Current Ratio | 1.64 | 1.58 | 2.28 | 2.32 | 2.72 | 1.99 | Upgrade
|
| Return on Equity (ROE) | 4.55% | 4.50% | 6.91% | 3.76% | 13.77% | 16.19% | Upgrade
|
| Return on Assets (ROA) | 2.95% | 3.04% | 3.16% | 1.92% | 7.10% | 7.09% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.23% | 5.42% | 5.86% | 4.93% | 17.54% | 19.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.90% | 5.90% | 5.80% | 3.80% | 12.70% | 15.10% | Upgrade
|
| Earnings Yield | 1.11% | 1.39% | 6.58% | 3.06% | 6.76% | 5.15% | Upgrade
|
| FCF Yield | 0.59% | -0.06% | -5.27% | -2.27% | 4.89% | 1.06% | Upgrade
|
| Dividend Yield | 0.72% | - | 3.05% | 5.39% | - | 1.32% | Upgrade
|
| Payout Ratio | 77.32% | 77.25% | 41.38% | 213.57% | 24.16% | 91.24% | Upgrade
|
| Buyback Yield / Dilution | 1.28% | 0.82% | 0.92% | -13.18% | -4.56% | -11.08% | Upgrade
|
| Total Shareholder Return | 2.01% | 0.82% | 3.97% | -7.78% | -4.56% | -9.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.